Transaction in Own Shares
Rhea-AI Summary
Shell (SHEL) announced on 10 December 2025 that it purchased shares for cancellation under its existing buy-back programme. Total shares purchased for cancellation: 1,507,757 shares (757,623 on LSE at VWAP £27.2388; 750,134 on XAMS at VWAP €31.2671).
The programme runs from 30 October 2025 to 30 January 2026, with Merrill Lynch International making independent trading decisions. Purchases follow UK MAR and EU MAR on-shored rules and the company’s on- and off-market authorities.
Positive
- Shares cancelled: 1,507,757 purchased for cancellation on 10/12/2025
- On- and off-market buy-back running through 30 January 2026 with independent broker execution
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves: CVX -0.38%, TTE -0.59%, BP -0.67% versus XOM +1.15% and PBR +1.82%. With SHEL at -0.21%, the pattern points to stock- and name-specific factors rather than a unified sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 08 | Share buy-back | Positive | -0.4% | Daily buy-back disclosure of cancellations across LSE, BATS and XAMS venues. |
| Dec 08 | Dividend detail | Positive | -0.4% | Announcement of Q3 2025 dividend currency equivalents and payment timetable. |
| Dec 05 | Share buy-back | Positive | -2.0% | Disclosure of 1,485,081 shares repurchased and cancelled under buy-back. |
| Dec 04 | Share buy-back | Positive | -0.8% | Report of 1,457,504 shares bought back across LSE and XAMS venues. |
| Dec 04 | Debt exchange offers | Neutral | -0.8% | Final results of multi-series note exchanges totaling $6.35B to optimize capital. |
Recent buy-back and capital actions have repeatedly coincided with modest negative next-day price moves, suggesting a pattern of short-term weakness around capital return and liability management headlines.
Over the last week, Shell has repeatedly reported daily share repurchases for cancellation, including multi-venue trades on 04–08 Dec 2025 under the buy-back programme running to 30 January 2026. It also detailed Q3 2025 dividend currency equivalents and finalized large debt exchange offers totaling $6,347,729,000. Despite generally shareholder-friendly themes (buy-backs, dividends, capital structure optimization), the stock posted negative 24-hour reactions after each release, framing today’s further buy-back disclosure within a pattern of near-term price softness on such news.
Market Pulse Summary
This announcement details further purchases of Shell’s ordinary shares for cancellation on 10 December 2025 across LSE and XAMS, as part of the buy-back programme running from 30 October 2025 to 30 January 2026. The programme is executed independently by Merrill Lynch International and structured under UK Listing Rules and EU/UK MAR. Investors may track cumulative repurchase volumes, execution prices in GBP and EUR, and how these actions interact with dividend policy and prior debt exchange activity.
Key Terms
uk listing rules regulatory
eu mar regulatory
uk mar regulatory
off-market buyback contract financial
AI-generated analysis. Not financial advice.
Transaction in Own Shares
10 December, 2025
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 10 December, 2025 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 10/12/2025 | 757,623 | 27.3900 | 27.0850 | 27.2388 | LSE | GBP |
| 10/12/2025 | - | - | - | - | Chi-X (CXE) | GBP |
| 10/12/2025 | - | - | - | - | BATS (BXE) | GBP |
| 10/12/2025 | 750,134 | 31.4100 | 31.1000 | 31.2671 | XAMS | EUR |
| 10/12/2025 | - | - | - | - | CBOE DXE | EUR |
| 10/12/2025 | - | - | - | - | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 October 2025.
In respect of this programme, Merrill Lynch International will make trading decisions in relation to the securities independently of the Company for a period from 30 October 2025 up to and including 30 January 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment